multiple

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian…

2 weeks ago

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

April 27, 2026 17:00 ET  | Source: Cabaletta Bio PHILADELPHIA, April 27, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq:…

1 month ago

Panchshil Realty Achieves Multiple ISO Certifications Across 12 Office Parks Spanning ~16.6 million Sq. Ft.

PUNE, India, April 17, 2026 /PRNewswire/ -- Panchshil Realty has achieved a significant milestone. Its 12 office parks (~ 16.6…

1 month ago

AION UT Achieves Strong Global Launch, Driving Robust Sales Across Key Markets and Earning Multiple International Honors

GUANGZHOU, China, April 15, 2026 /PRNewswire/ -- Since its 2025 global debut, the AION UT has rapidly gained traction across Southeast…

2 months ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products

SHANGHAI, April 4, 2026 /PRNewswire/ -- From April 2 to 31, the Assembly Character Toys brand Blokees made its debut…

2 months ago

Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC

Lyon (France), March 26, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its…

2 months ago

Curaechoice and Fast Pace Health Partner to Expand Affordable Healthcare Access Across Multiple States

Curaechoice members now have enhanced access to covered services at over 300 Fast Pace Health clinics at $0 cost February…

3 months ago

TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis

Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create space for honest conversation among…

4 months ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the…

4 months ago

Blokees Exhibits Multiple Products at Spielwarenmesse 2026

SHANGHAI, Jan. 28, 2026 /PRNewswire/ -- From January 27 to 31, Assembly Character Toys brand Blokees appeared at Spielwarenmesse 2026,…

4 months ago